Skip to content

The Effect of rTEM in the Prognosis and Severity of Sepsis Induced ARDS

The Effect of rTEM in the Prognosis and Severity of Sepsis Induced ARDS

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06063707
Enrollment
90
Registered
2023-10-02
Start date
2023-10-01
Completion date
2024-09-01
Last updated
2023-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Brief summary

To observe the changes of plasma rTEM levels in patients with sepsis, sepsis induced ARDS, and to explore its clinical significance.

Detailed description

90 patients will be included in this study. Blood samples from these patients in the first day, the third day, were maintained and tested to detect the change of rTEM level. Severity of illness and survival status of every patient were recorded within 28 days. The objective is to observe the changes of plasma rTEM levels in patients with sepsis, sepsis induced ARDS, and to explore its clinical significance.

Interventions

Taking peripheral blood of no more than 3ml

Sponsors

Southeast University, China
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Diagnosed as Sepsis 3.0 Patients signing informed consent

Exclusion criteria

Pregnant women Patients with tumor、hepatitis、liver cirrhosis、acute myocardial infarction、chronic renal tubular nephritis、interstitial pneumonia、acute pancreatitis、systemic lupus erythenatosus、ulcerative colitis、crohn's disease、HELLP syndrome

Design outcomes

Primary

MeasureTime frameDescription
Mortality28 day28day mortality

Contacts

Primary ContactJingyuan Xu, M.D.
13851417209@163.com008613851417209

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026